2023
Identification of risk factors and mosquito vectors associated with dengue virus infection in American Samoa, 2017
Sharp T, Tufa A, Cotter C, Lozier M, Santiago G, Johnson S, Mataia’a M, Waterman S, Muñoz-Jordán J, Paz-Bailey G, Hemme R, Schmaedick M, Anesi S. Identification of risk factors and mosquito vectors associated with dengue virus infection in American Samoa, 2017. PLOS Global Public Health 2023, 3: e0001604. PMID: 37418355, PMCID: PMC10328243, DOI: 10.1371/journal.pgph.0001604.Peer-Reviewed Original ResearchDENV infectionIgM ELISARisk factorsRT-PCRDENV-2Dengue virus infectionPopulation-specific risk factorsFrequency of infectionDENV nucleic acidMosquito vectorsOutbreak of dengueCluster investigationsFebrile illnessMedian ageResidents of householdsRole of AeDengue patientsVirus infectionDENV transmissionSerum specimensZika virusPatient specimensBivariate analysisInfectionAdult female mosquitoes
2021
Early Release - Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines - Volume 27, Number 12—December 2021 - Emerging Infectious Diseases journal - CDC
Adams C, Jadi R, Segovia-Chumbez B, Daag J, Ylade M, Medina F, Sharp T, Munoz-Jordan J, Yoon I, Deen J, Lopez A, de Silva A, Premkumar L. Early Release - Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines - Volume 27, Number 12—December 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 3073-3081. PMID: 34808091, PMCID: PMC8632176, DOI: 10.3201/eid2712.211150.Peer-Reviewed Original ResearchConceptsZIKV seroprevalenceDENV transmissionEnvelope domain IIIZika virusSerologic assaysInfectious Diseases journal - CDCType-specific antibodiesDengue virus serotypesYears of agePublic health laboratoriesRelated flavivirusesHealth laboratoriesFlaviviridae familySeroprevalenceChildren 9Virus serotypesDomain IIIVirusAntibodiesAssaysDENVFlavivirusesEstimating incidence of infection from diverse data sources: Zika virus in Puerto Rico, 2016
Quandelacy T, Healy J, Greening B, Rodriguez D, Chung K, Kuehnert M, Biggerstaff B, Dirlikov E, Mier-y-Teran-Romero L, Sharp T, Waterman S, Johansson M. Estimating incidence of infection from diverse data sources: Zika virus in Puerto Rico, 2016. PLOS Computational Biology 2021, 17: e1008812. PMID: 33784311, PMCID: PMC8034731, DOI: 10.1371/journal.pcbi.1008812.Peer-Reviewed Original ResearchConceptsGuillain-Barré syndrome casesBlood bank dataIncidence of infectionZika virus epidemicSubset of casesSyndrome casesWeekly infectionsUnderlying incidenceZika virusArboviral casesInfectionSurveillance dataEpidemic preparednessZika epidemicVirus epidemicEpidemicIncidenceLarge proportionCasesWeeks
2020
Epidemiologic and spatiotemporal trends of Zika Virus disease during the 2016 epidemic in Puerto Rico
Sharp T, Quandelacy T, Adams L, Aponte J, Lozier M, Ryff K, Flores M, Rivera A, Santiago G, Muñoz-Jordán J, Alvarado L, Rivera-Amill V, Garcia-Negrón M, Waterman S, Paz-Bailey G, Johansson M, Rivera-Garcia B. Epidemiologic and spatiotemporal trends of Zika Virus disease during the 2016 epidemic in Puerto Rico. PLOS Neglected Tropical Diseases 2020, 14: e0008532. PMID: 32956416, PMCID: PMC7529257, DOI: 10.1371/journal.pntd.0008532.Peer-Reviewed Original ResearchConceptsZIKV diseaseDisease casesZika virusZIKV infectionArboviral diseasesEvidence of infectionZika virus diseaseLaboratory-based surveillancePuerto Rico DepartmentPublic health authoritiesIgM ELISAZIKV epidemicHigh incidenceChikungunya virusLaboratory evidenceHealth authoritiesDiseaseEarly detectionRT-PCRInfectionSocioeconomic factorsVirus diseaseEpidemicEarlier midpointIncidence
2017
Persistence of Zika Virus in Body Fluids — Final Report
Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L, Perez-Padilla J, Medina FA, Waterman SH, Adams L, Lozier M, Bertrán-Pasarell J, Garcia Gubern C, Alvarado L, Sharp T. Persistence of Zika Virus in Body Fluids — Final Report. New England Journal Of Medicine 2017, 379: 1234-1243. PMID: 28195756, PMCID: PMC5831142, DOI: 10.1056/nejmoa1613108.Peer-Reviewed Original ResearchZIKV RNAZIKV RNA detectionVaginal secretionsIgM enzyme-linked immunosorbentDetectable ZIKV RNARNA detectionZika virus RNAEnzyme-linked immunosorbentZIKV exposureZIKV infectionWeek 4RNA clearanceZika virusSurveillance sitesFirst monthRT-PCRSerumVirus RNAMonthsBody fluidsUrineSecretionDaysMedianRegression modelsZika Virus -10 Public Health Achievements in 2016 and Future Priorities.
Oussayef N, Pillai S, Honein M, Ben Beard C, Bell B, Boyle C, Eisen L, Kohl K, Kuehnert M, Lathrop E, Martin S, Martin R, McAllister J, McClune E, Mead P, Meaney-Delman D, Petersen B, Petersen L, Polen K, Powers A, Redd S, Sejvar J, Sharp T, Villanueva J, Jamieson D. Zika Virus -10 Public Health Achievements in 2016 and Future Priorities. MMWR Morbidity And Mortality Weekly Report 2017, 65: 1482-1488. PMID: 28056005, DOI: 10.15585/mmwr.mm6552e1.Peer-Reviewed Original ResearchConceptsZika virusPregnant womenZika virus infectionEffective reversible contraceptionPersonal protective practicesPublic health achievementsPublic health activitiesPublic health agenciesPublic health emergencyWorld Health OrganizationSexual transmissionUnintended pregnancyReversible contraceptionVirus infectionCongenital microcephalyEmergency Operations CenterHealth achievementsHealth activitiesHealth agenciesHealth OrganizationHealth emergencyPregnancyVirusProtective practicesWomen